Nutrien
NTR
63.84
-1.57
-2.40%
Nutrien
US · NTR
#621 by market cap
Listed 1970
63.84
-1.57
-2.40%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
C
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Improving
7 2
■ Upgrades■ Downgrades
- 7 upgrades vs 2 downgrades among tracked analyst rating changes.
- The single most recent change was actually a downgrade (Jefferies moved from Buy to Hold on 2026-10-12), though the broader window skews toward upgrades.
Analyst consensus 14 analysts
Buy
Avg price target 80.31 +25.8%
Price target rangecurrent 63.84
Low62.00
Avg80.31
High108.00
Buy 64%
Hold 29%
Sell 7%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-06 | Morgan Stanley | -- | Buy | 76.00 |
| 2026-11-05 | Scotiabank | -- | Buy | 80.00 |
| 2026-11-05 | Barclays | -- | Buy | 78.00 |
| 2026-11-05 | Oppenheimer | -- | Buy | 108.00 |
| 2026-10-27 | UBS | -- | Sell | 62.00 |
| 2026-10-27 | Freedom Capital Markets | -- | Hold | 78.00 |
| 2026-10-26 | UBS | -- | Sell | 62.00 |
| 2026-10-22 | Oppenheimer | -- | Buy | 78.00 |
| 2026-10-19 | BofA Securities | -- | Buy | 80.00 |
| 2026-10-16 | Barclays | -- | Buy | 78.00 |
| 2026-10-14 | UBS | -- | Sell | -- |
| 2026-10-13 | RBC Capital | -- | Buy | 85.00 |
| 2026-10-12 | Jefferies | -- | Hold | 71.00 |
| 2026-10-07 | Morgan Stanley | -- | Buy | 76.00 |
| 2026-10-06 | BMO Capital | -- | Buy | 82.00 |
| 2026-10-05 | RBC Capital | -- | Buy | 85.00 |
| 2026-09-17 | RBC Capital | -- | Buy | 85.00 |
| 2026-09-14 | RBC Capital | -- | Buy | 85.00 |
| 2026-09-11 | KeyBanc | -- | Hold | -- |
| 2026-08-24 | National Bank | -- | Hold | 77.00 |
| 2026-08-11 | TD Cowen | -- | Buy | 83.00 |
| 2026-08-11 | Barclays | -- | Buy | 78.00 |
| 2026-08-10 | Morgan Stanley | -- | Buy | 76.00 |
| 2026-08-10 | RBC Capital | -- | Buy | 85.00 |
| 2026-08-10 | CIBC | -- | Buy | 84.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-10-12 | Jefferies | Buy → Hold | 71.00 |
| 2026-07-28 | BNP Paribas | Hold → Buy | 80.00 |
| 2026-06-30 | Scotiabank | Hold → Buy | 80.00 |
| 2026-06-03 | Wells Fargo | Hold → Buy | 90.00 |
| 2026-04-30 | BofA Securities | Hold → Buy | 82.00 |
| 2026-04-27 | Barclays | Hold → Buy | 85.00 |
| 2026-03-25 | UBS | Hold → Sell | 67.00 |
| 2026-03-12 | Jefferies | Hold → Buy | 96.00 |
| 2026-01-14 | Morgan Stanley | Hold → Buy | 77.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-05 | -- | ±4.23% | -1.01% (in line) |
| 2026/Q2 | 2026-08-05 | After close | ±3.09% | -0.24% (in line) |
| 2026/Q1 | 2026-05-06 | After close | ±3.80% | -7.36% (beat) |
| 2025/Q4 | 2026-02-18 | After close | ±3.83% | +2.13% (in line) |
| 2025/Q3 | 2025-11-05 | After close | ±3.14% | +2.94% (in line) |
| 2025/Q2 | 2025-08-06 | After close | ±4.43% | -3.87% (in line) |
| 2025/Q1 | 2025-05-07 | After close | ±4.39% | -3.30% (in line) |
| 2024/Q4 | 2025-02-20 | -- | ±3.67% | -1.05% (in line) |
| 2024/Q3 | 2024-11-06 | After close | ±5.22% | -1.15% (in line) |
| 2024/Q2 | 2024-08-07 | After close | ±5.26% | -2.23% (in line) |
| 2024/Q1 | 2024-05-08 | After close | ±4.60% | +4.94% (beat) |
| 2023/Q4 | 2024-02-21 | After close | ±5.48% | +7.36% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Nutrien discussion 0 comments